Home page | Archivio della ricerca dell'Università di Modena e Reggio Emilia

Ricerca

Inserisci parole chiave

Nuova ricerca

Aggiungere filtri:

Paginazione

Risultati/pagina

Informazioni

Info IRIS Unimore

Guida IRIS Unimore

VQR 2015-2019

ASN 2018-2020

Contatti

News

Prodotti recenti

Cluster analysis identifies patients at risk of catheter-associated urinary tract infections in intensive care units: findings from the SPIN-UTI Network

Background: Although preventive strategies have been proposed against catheter-associated urinary tract infections (CAUTIs) in intensive care units (ICUs), more efforts are needed to control the incidence rate. Aim: To distinguish patients according to their characteristics at ICU admission, and to&#x...

Unravelling Heterogeneity of Amplified Human Amniotic Fluid Stem Cells Sub-Populations

Human amniotic fluid stem cells (hAFSCs) are broadly multipotent immature progenitor cells with high self-renewal and no tumorigenic properties. These cells, even amplified, present very variable morphology, density, intracellular composition and stemness potential, and this heterogeneity can hinder their&...

Changes in central adipose tissue after switching to integrase inhibitors

Background: Treatment with integrase strand transfer inhibitors (INSTIs) has been associated with excess weight gain, however the long-term effect of INSTI-based regimens on adipose tissue (AT) compartments remains unknown. Objectives: To evaluate the effect of switching to an INSTI on visceral&#...

Weight gain during pregnancy in women with HIV receiving different antiretroviral regimens

No published studies have evaluated in pregnant women with HIV weight gain with different antiretroviral drug classes.

Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature

Purpose: Post-neurosurgical infection caused by extensively drug resistant Pseudomonas aeruginosa (XDR-PA) are becoming a matter of great concern due to limited therapeutic options. Although not approved for these indications, the new BetaLactam-BetaLactamase Inhibitor combinations (BLBLIs) could represent a&#x...